A facile and scalable in production non-viral gene engineered mesenchymal stem cells for effective suppression of temozolomide-resistant (TMZR) glioblastoma growth
10.1186/s13287-020-01899-x
Saved in:
Main Authors: | Tu, G.X.E., Ho, Y.K., Ng, Z.X., Teo, K.J., Yeo, T.T., Too, H.-P. |
---|---|
Other Authors: | BIOCHEMISTRY |
Format: | Article |
Published: |
BioMed Central Ltd
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/199709 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Combined temozolomide and radiation as an initial treatment for anaplastic glioma
by: Tham, C.K., et al.
Published: (2016) -
Improved median survival for glioblastoma multiforme following introduction of adjuvant temozolomide chemotherapy
by: Back, M.F., et al.
Published: (2016) -
Characterization of a side population of astrocytoma cells in response to temozolomide: Laboratory investigation
by: Chua, C., et al.
Published: (2014) -
Dual p38MAPK and MEK inhibition disrupts adaptive chemoresistance in mesenchymal glioblastoma to temozolomide
by: Cheng, Hong Sheng, et al.
Published: (2024) -
MESENCHYMAL STEM CELLS AS THERAPY AGAINST HUMAN GLIOBLASTOMA MULTIFORME
by: YULYANA
Published: (2014)